2008-02-05 - Female - 18 Years old
303300
| Adverse reaction report number | 303300 |
| Latest AER version number | 0 |
| Market authorization holder AER number | N/A |
| Initial received date | 2008-02-05 |
| Latest received date | 2008-02-05 |
| Age | 18 Years |
| Gender | Female |
| Weight | N/A |
| Type of report | Spontaneous |
| Reporter type | Pharmacist |
| Source of report | Community |
| Report outcome | Recovered/resolved |
| Serious report? | Yes |
Reason for seriousness
| Death | |
| Disability | |
| Cogenital anomaly | |
| Life threateting | |
| Hospitalization | |
| Other medically important | Yes |
| Product description | Dosage form | Health product role | Route of administration | Dose | Frequency | Therapy duration | Indication(s) |
|---|---|---|---|---|---|---|---|
| ADDERALL XR 20MG | CAPSULE, EXTENDED RELEASE | Suspect | Oral | 20 Milligram | 1 every 1 Day(s) | 5 Day(s) | Attention deficit/hyperactivity disorder |
| DIFFERIN XP | GEL | Concomitant | Unknown | ||||
| MINOCYCLINE | NOT SPECIFIED | Concomitant | Oral | ||||
| VENLAFAXINE | NOT SPECIFIED | Concomitant | Oral |
| MedDRA version: v.21.1 | |
| Adverse reaction terms | Reaction duration |
|---|---|
| Asthenia | |
| Depressed level of consciousness | |
| Fatigue | |
| Hypersomnia | |
| Limb discomfort | |
| Loss of personal independence in daily activities | |
| Palpitations | |